Macugen for Proliferative Diabetic Retinopathy Study With Extended Dosing (M-PDRS ED)
This study is ongoing, but not recruiting participants.
Sponsor:
Valley Retina Institute
Collaborator:
Pfizer
Information provided by (Responsible Party):
Victor H. Gonzalez, MD, Valley Retina Institute
ClinicalTrials.gov Identifier:
NCT01486771
First received: December 2, 2011
Last updated: December 5, 2011
Last verified: December 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | February 2014 |
| Estimated Primary Completion Date: | August 2013 (Final data collection date for primary outcome measure) |